Dr. Layton Smith is the Director of Drug Discovery and Exploratory Pharmacology for the Conrad Prebys Center for Chemical Genomics (Prebys Center) at Sanford Burnham Prebys Medical Discovery Institute at Lake Nona (SBP). He is also the Principal Investigator for the Florida Translational Research Program at SBP, Florida’s state-funded program for drug discovery.
Prior to joining Sanford Burnham Prebys, Layton was the Associate Director of Pharmacology at The Scripps Research Institute where he led the in vitro ADME/T and in vivo DMPK teams in support of several discovery projects spanning oncology, diabetes, and vascular diseases. After moving to SBP, he established a Pharmacology core facility to complement the small molecule discovery platforms already in existence. In 2009, Layton was promoted to Director of Drug Discovery. Since then, he has been involved in center leadership, strategic planning, and in the coordination of effort between the project teams of the Center and its collaborators to execute projects on schedule and on budget.
Layton received his doctorate degree (Pharmacology, 2002) from Vanderbilt University, Nashville, Tennessee, where he also received his postdoctoral training in Clinical Pharmacology and Cardiovascular Medicine.
